Predicting treatment outcomes using F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapy

Predicting treatment outcomes using F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapy

Background: Predictive markers for treatment response and survival outcome have not been identified in patients with advanced non-small-cell lung cancer (NSCLC) receiving chemoimmunotherapy. We aimed to evaluate whether imaging biomarkers of 18 F-fluorodeoxyglucose ( 18 F-FDG) positron emission tomo...

Full description

Bibliographic Details
Main Authors: Chang Gon Kim, Sang Hyun Hwang, Kyung Hwan Kim, Hong In Yoon, Hyo Sup Shim, Ji Hyun Lee, Yejeong Han, Beung-Chul Ahn, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho, Arthur Cho, Sun Min Lim
Format: Article
Language:English
Published: SAGE Publishing 2022-01-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359211068732

Internet

https://doi.org/10.1177/17588359211068732

Similar Items